Local view for "http://purl.org/linkedpolitics/eu/plenary/2000-07-05-Speech-3-255"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2000-07-05"^^xsd:date2
dcterms:Is Part Of	lp_eu:Proposal for a regulation on a Community patent2
dcterms:Language	"fr"^^xsd:language2
lpv:document identification number	"en.20000705.8.3-255"2
lpv:hasSubsequent	lp_eu:2000-07-05-Speech-3-2562
lpv:speaker	lp:Geneviève Fraisse2
lpv:spokenAs	member; EUL/NGL (1999-07-20--2004-07-19)3 substitute; Committee on Legal Affairs and the Internal Market (1999-07-21--2002-01-14)3 unknown; Indépendant (1999-07-20--2004-07-19)3 member; Committee on Culture, Youth, Education, the Media and Sport (1999-07-21--2002-01-14)3 member; Committee on Women's Rights and Equal Opportunities (1999-07-21--2002-01-14)3 member; Delegation for relations with the United States (1999-09-29--2002-01-14)3
lpv:translated text	"Mr President, Commissioner, the proposal for a regulation on a Community patent gives us the chance to review cooperation, as you have just said, between the European Patent Office and the Community institutions. The patent recently issued to the University of Edinburgh poses the problem of the status of the EPO and how to control it. In the light of what has now been referred to as a mistake, it would appear that Directive 98/44 on the legal protection of biotechnological inventions is inaccurate and ambiguous, especially Articles 5(1) and 5(2). Should the Commission not propose a revision of this directive in order to preclude the possibility of patenting the discovery of a gene or genetic sequence? We must not skimp on this question, especially now that we are introducing a Community patent."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph